Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$69.25 - $82.21 $1.21 Million - $1.43 Million
17,450 New
17,450 $1.22 Million
Q1 2023

May 15, 2023

SELL
$58.39 - $75.0 $71,410 - $91,725
-1,223 Reduced 5.11%
22,732 $1.4 Million
Q4 2022

Feb 13, 2023

BUY
$39.94 - $79.72 $956,762 - $1.91 Million
23,955 New
23,955 $1.85 Million
Q1 2022

May 13, 2022

SELL
$23.7 - $41.39 $201,639 - $352,146
-8,508 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$30.7 - $43.36 $61,185 - $86,416
1,993 Added 30.59%
8,508 $321,000
Q3 2021

Nov 12, 2021

BUY
$19.91 - $68.26 $129,713 - $444,713
6,515 New
6,515 $215,000
Q3 2020

Nov 06, 2020

SELL
$68.34 - $85.84 $690,370 - $867,155
-10,102 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$49.87 - $98.69 $948,427 - $1.88 Million
-19,018 Reduced 65.31%
10,102 $831,000
Q1 2020

May 08, 2020

BUY
$41.2 - $101.31 $1.1 Million - $2.72 Million
26,809 Added 1160.06%
29,120 $1.71 Million
Q4 2019

Feb 12, 2020

SELL
$16.71 - $106.24 $246,606 - $1.57 Million
-14,758 Reduced 86.46%
2,311 $239,000
Q3 2019

Nov 08, 2019

BUY
$20.24 - $29.16 $345,476 - $497,732
17,069 New
17,069 $345,000
Q1 2018

May 03, 2018

SELL
$2.35 - $5.6 $53,840 - $128,301
-22,911 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$4.45 - $6.2 $101,953 - $142,048
22,911
22,911 $128,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.44B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.